Profile data is unavailable for this security.
About the company
Accent Microcell Limited is a global manufacturer of microcrystalline cellulose. It is engaged in the manufacturing of a pharmaceutical excipients range of products. Its segments include Dahej (SEZ Unit), Pirana, and Unit III. It serves various applications, including pharmaceuticals and nutraceuticals; food, bakery and dairy; cosmeceuticals and personal care; textile, leather, paper, and boards; paints, ceramic, construction and cements; welding electrodes; rubber; filtration, plastics. Its comprehensive product portfolio is designed to meet the diverse needs of the pharmaceutical, nutraceutical, food, cosmetic and other industries. Its range includes binders, fillers, target-drug-delivery, disintegrants, lubricants, coatings, and preservatives. Its products include Micro Crystalline Cellulose, Cellulose Powder, Microcrystalline Cellulose Spheres, Silicified Microcrystalline Cellulose, Cross Carmellose Sodium and Magnesium Stearate. It has a global presence spanning over 75 countries.
- Revenue in INR (TTM)2.78bn
- Net income in INR346.64m
- Incorporated2012
- Employees192.00
- LocationAccent Microcell LtdAHMEDABAD 380015IndiaIND
- Phone+91 7 940042367
- Websitehttps://accentmicrocell.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kilitch Drugs (India) Ltd | 2.07bn | 264.30m | 5.68bn | 187.00 | 20.46 | -- | 20.37 | 2.74 | 15.87 | 15.87 | 123.46 | -- | -- | -- | -- | 11,074,770.00 | -- | 5.16 | -- | 7.38 | 35.29 | 35.37 | 12.18 | 8.41 | -- | 4.54 | -- | 0.00 | 28.47 | 30.05 | 82.86 | 99.64 | 34.88 | -- |
| Shri Ahimsa Naturals Ltd | 1.16bn | 266.73m | 5.78bn | -- | 16.83 | 3.41 | 20.26 | 5.00 | 14.65 | 14.65 | 61.23 | 72.37 | 0.7957 | 1.80 | 4.75 | -- | 18.36 | 25.55 | 19.42 | 31.51 | 48.63 | 53.50 | 23.07 | 25.19 | 12.68 | -- | 0.00 | -- | 22.86 | 34.75 | 17.31 | 78.70 | 53.34 | -- |
| Kopran Ltd | 6.20bn | 165.43m | 6.40bn | 1.02k | 38.85 | -- | 19.18 | 1.03 | 3.41 | 3.41 | 128.28 | -- | -- | -- | -- | 6,052,426.00 | -- | 7.85 | -- | 11.25 | 34.20 | 32.04 | 2.67 | 8.66 | -- | 2.39 | -- | 29.60 | 2.44 | 11.86 | -24.34 | 12.90 | 33.20 | -- |
| Anlon Healthcare Ltd | 1.70bn | 346.64m | 6.46bn | 101.00 | 16.49 | -- | 17.60 | 3.80 | 7.37 | 7.37 | 37.66 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 38.31 | -- | 20.39 | -- | -- | 11.05 | -- | -- | 80.65 | -- | 112.46 | -- | -- | -- |
| Fabtech Technologies Ltd | 3.87bn | 313.94m | 7.12bn | -- | 16.19 | -- | 19.75 | 1.84 | 9.89 | 9.89 | 115.93 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 44.01 | -- | 8.11 | -- | -- | -- | -- | -- | 44.46 | -- | 70.67 | -- | -- | -- |
| Accent Microcell Ltd | 2.78bn | 346.64m | 7.84bn | 192.00 | 21.46 | 3.14 | 20.16 | 2.82 | 15.24 | 15.24 | 122.20 | 104.07 | 1.12 | 4.14 | 5.32 | 14,474,330.00 | 13.99 | -- | 15.95 | -- | 39.96 | -- | 12.47 | -- | 3.01 | 76.48 | 0.0046 | -- | 7.77 | -- | 9.60 | -- | -- | -- |
| Remus Pharmaceuticals Ltd | 7.48bn | 325.59m | 8.07bn | 68.00 | 22.02 | 2.63 | 18.35 | 1.08 | 31.11 | 31.11 | 701.20 | 260.51 | 1.89 | 9.07 | 7.21 | 109,981,700.00 | 10.44 | 14.37 | 18.44 | 28.60 | 13.01 | 19.39 | 5.51 | 8.39 | 1.07 | 35.59 | 0.0452 | 3.59 | 191.93 | 120.44 | 34.98 | 104.56 | 48.07 | -- |
| Anuh Pharma Ltd | 7.68bn | 418.22m | 8.19bn | 295.00 | 19.57 | -- | 15.47 | 1.07 | 4.17 | 4.17 | 76.65 | -- | -- | -- | -- | 26,023,040.00 | -- | 10.41 | -- | 17.00 | 22.25 | 23.95 | 5.45 | 7.35 | -- | 116.27 | -- | 26.59 | 2.24 | 16.60 | -21.16 | 27.05 | -10.78 | 16.89 |
| Themis Medicare Ltd | 3.37bn | -174.06m | 8.38bn | 1.76k | -- | -- | -- | 2.49 | -1.89 | -1.89 | 36.52 | -- | -- | -- | -- | 1,917,083.00 | -- | 10.17 | -- | 14.38 | 62.56 | 60.61 | -5.16 | 13.52 | -- | -3.71 | -- | 9.36 | 6.22 | 15.00 | -31.46 | 3.78 | 21.58 | 23.36 |
| Sigachi Industries Ltd | 5.06bn | -550.46m | 8.82bn | 1.10k | -- | 1.74 | -- | 1.74 | -1.46 | -1.46 | 13.20 | 13.29 | 0.6316 | 2.40 | 2.80 | 4,624,222.00 | -6.70 | 12.29 | -9.77 | 16.21 | 52.83 | 51.93 | -10.62 | 14.80 | 1.27 | 5.53 | 0.2436 | 4.23 | 22.38 | 28.55 | 21.66 | 27.91 | 48.87 | -- |
| Wanbury Ltd | 6.58bn | 646.86m | 9.00bn | 1.38k | 13.47 | -- | 11.37 | 1.37 | 19.13 | 19.13 | 194.16 | -- | -- | -- | -- | 4,758,967.00 | -- | 8.87 | -- | 101.40 | 55.07 | 41.82 | 9.84 | 5.62 | -- | 2.97 | -- | -- | 4.15 | 10.29 | -45.44 | -13.88 | 44.32 | -- |
| Venus Remedies Ltd | 7.00bn | 762.95m | 10.01bn | 1.30k | 13.12 | -- | 10.02 | 1.43 | 57.10 | 57.10 | 523.77 | -- | -- | -- | -- | 5,391,957.00 | -- | 6.67 | -- | 8.08 | 47.02 | 37.62 | 10.90 | 6.87 | -- | 1,849.19 | -- | -- | 7.72 | 13.81 | 59.05 | -- | 18.36 | -- |
